找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Melanoma; Howard L. Kaufman,Janice M. Mehnert Book 2016 Springer International Publishing Switzerland 2016 Diagnosis.Immunotherapy.Melanom

[复制链接]
查看: 12005|回复: 55
发表于 2025-3-21 17:32:12 | 显示全部楼层 |阅读模式
书目名称Melanoma
编辑Howard L. Kaufman,Janice M. Mehnert
视频video
概述Concise, up-to-date overview of the diagnosis, treatment, and prevention of melanoma.Reviews advances in basic science.Covers current and evolving treatment strategies in the adjuvant, metastatic, and
丛书名称Cancer Treatment and Research
图书封面Titlebook: Melanoma;  Howard L. Kaufman,Janice M. Mehnert Book 2016 Springer International Publishing Switzerland 2016 Diagnosis.Immunotherapy.Melanom
描述.Melanoma is one of the most types of cancer. When melanoma is detected at an early stage, treatment is highly successful, but outcomes can be poor when the disease is advanced. There has been significant progress in our understanding of the molecular biology, genetics, and immunology of melanoma over the past decade. This has been accompanied by rapid advances in therapeutic strategies for patients with melanoma. This book provides the clinician and the researcher with a broad understanding of the molecular and cellular pathogenesis of melanoma, explores the clinical characteristics and criteria for clinical and pathological staging of the disease, and provides an overview of current and evolving treatment strategies in the adjuvant, metastatic, and preventive settings. The treatment of special populations and rare variants of melanoma that often present particular clinical challenges is also covered. Authored by international experts in melanoma biology and clinical management, this volume concisely explains how to diagnose, treat, and prevent melanoma while reviewing advances in basic science and providing an overview of innovative approaches still under development..
出版日期Book 2016
关键词Diagnosis; Immunotherapy; Melanoma; Prevention; Treatment
版次1
doihttps://doi.org/10.1007/978-3-319-22539-5
isbn_softcover978-3-319-34637-3
isbn_ebook978-3-319-22539-5Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightSpringer International Publishing Switzerland 2016
The information of publication is updating

书目名称Melanoma影响因子(影响力)




书目名称Melanoma影响因子(影响力)学科排名




书目名称Melanoma网络公开度




书目名称Melanoma网络公开度学科排名




书目名称Melanoma被引频次




书目名称Melanoma被引频次学科排名




书目名称Melanoma年度引用




书目名称Melanoma年度引用学科排名




书目名称Melanoma读者反馈




书目名称Melanoma读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:28:29 | 显示全部楼层
发表于 2025-3-22 02:49:56 | 显示全部楼层
Adjuvant Therapy of Melanoma,2b (HDI) is the main adjuvant therapeutic mainstay in high-risk disease following definitive resection. In this chapter, we review the evidence supporting the use of adjuvant HDI in high-risk melanoma. We also discuss some of the other treatment modalities that have been evaluated including vaccines, chemotherapy, and radiotherapy.
发表于 2025-3-22 08:32:48 | 显示全部楼层
发表于 2025-3-22 10:52:27 | 显示全部楼层
Pediatric Melanoma and Atypical Melanocytic Neoplasms,anoma and atypical melanocytic neoplasms, including the roles of and unresolved questions surrounding sentinel lymph node biopsy, completion lymphadenectomy, adjuvant therapy, and treatment of advanced disease.
发表于 2025-3-22 13:38:50 | 显示全部楼层
发表于 2025-3-22 17:13:48 | 显示全部楼层
Checkpoint Blockade for the Treatment of Advanced Melanoma,future directions, including combination strategies. This chapter is focused on melanoma, but the principles related to this immunotherapy approach are applicable to patients with many types of malignancies.
发表于 2025-3-23 01:07:35 | 显示全部楼层
发表于 2025-3-23 02:58:43 | 显示全部楼层
发表于 2025-3-23 05:33:03 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-17 07:28
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表